Background. -Elderly patients are increasingly referred for complex percutaneous coronary interventions (PCI), including recanalization of chronic total occlusion (CTO). Aims. -To assess the feasibility, safety and clinical benefits associated with CTO-PCI in elderly patients. Methods. -Consecutive patients (n = 356) who underwent CTO-PCI in our institution between January 2008 and December 2011 were prospectively included. The short-term outcomes of CTO-PCI were assessed by comparing the rates of successful recanalization and postoperative Abbreviations: ACS, acute coronary syndrome; CAD, coronary artery disease; CTO, chronic total occlusion; MACCE, major adverse cardiac or cerebrovascular event; MACE, major adverse cardiac event; PCI, percutaneous coronary intervention. 14 R. André et al. complications in patients aged ≥75 years and those <75 years. The clinical effect of successful recanalization was evaluated in a 20-month follow-up analysis in patients ≥75 years.
Background
Life expectancy has increased in recent decades, in part due to medical advances. As a result, more elderly patients are being referred to cardiologists for treatment of coronary artery disease (CAD), but the optimal management in those aged 75 years and older is debated. Indeed, the benefits of aggressive revascularization in elderly patients have been poorly investigated in randomized trials, and numerous studies have reported a higher risk of postoperative complications [1, 2] and lower procedural success rates with percutaneous coronary intervention (PCI) [3] in the elderly. Techniques have improved, however, and evidence from more recent studies has suggested that elderly patients could, paradoxically, benefit more than younger patients from appropriate interventional revascularization [4] . In clinical practice, older patients still have the lowest rates of revascularization [5] and this is especially true for elderly patients with chronic total coronary occlusion (CTO). Indeed, studies have shown that because of the lower success rates of recanalization (60-70%), a minority of patients with CTO (8-15%) are referred for PCI [6] [7] [8] [9] .
The prevalence of CTO rises with age [10] and can affect more than 30% of older patients suspected of having myocardial ischaemia [7] , but there is no clear evidence on the best way to manage these patients. Indirect evidence from non-randomized studies suggests that CTO-PCI could improve survival and relieve symptoms related to myocardial ischaemia [11, 12] , but there is a paucity of data describing CTO-PCI among the elderly. Moreover, most studies on elderly patients were carried out 10 years ago [12] and do not take into account the recent technical improvements in CTO-PCI (including widespread use of drug-eluting stents and CTO-dedicated devices) that have probably improved the outcome of CTO-PCI in elderly patients [13] .
The aim of our study was to develop a comprehensive single-centre registry including all patients undergoing CTO-PCI in our department, to evaluate the feasibility, safety and outcomes of CTO-PCI in the elderly population (≥75 years).
Methods

Population
All consecutive patients referred to the Rangueil University Hospital, Toulouse, France for PCI of a chronically occluded native coronary vessel between January 2008 and December 2011 were included in the registry. Patients were divided into two age groups (<75 and ≥75 years). A CTO was angiographically defined as a complete occlusion with no anterograde filling of the distal vessel within the occluded segment [14] . The duration of occlusion was assessed by the clinical history and previous angiograms. All patients referred for PCI had myocardial viability in the territory of CTO and persistent symptoms related to ischaemia despite optimal medical therapy, or extensive silent myocardial ischaemia documented by stress imaging such as magnetic resonance imaging, scintigraphy or echocardiography. The exclusion criterion was an estimated CTO duration of <3 months.
Data on patient baseline characteristics, procedural details and in-hospital outcomes were collected from medical records and a database by a trained medical investigator. Quality controls were performed before analysis. Chronic pulmonary disease was defined as the long-term use of bronchodilators or steroids for lung disease and the EuroSCORE was calculated according to the EuroSCORE I additive scoring method. Creatinine clearance was calculated according to the Modification of Diet in Renal Disease formula. Moderate chronic kidney was defined as creatinine clearance between 30 and 59 mL/min and severe disease as creatinine clearance <30 mL/min. Symptoms suggestive of congestive heart failure were classified according to the New York Heart Association (NYHA) classification and symptoms of angina according to the Canadian Cardiovascular Society (CCS) classification. Left ventricular ejection fraction was evaluated by echocardiography, magnetic resonance imaging or ventriculography.
Procedures
Procedures were performed according to the operators' standard practices via a radial or femoral approach, and a retrograde approach was used when required.
Procedural success was defined as the restoration of an anterograde flow, with thrombosis in myocardial infarction (TIMI) flow grade 2 or 3 and a residual stenosis of <30% on angiography.
End-points and follow-up
For in-hospital outcomes, major adverse cardiac and cerebrovascular events (MACCE) were defined as the composite of death, myocardial infarction or stroke. Haemorrhage was defined as a drop in haemoglobin >3 g/dL [15] and acute renal failure as a >25% rise in creatinine within the first 48 hours following PCI [16, 17] . The performance of coronary artery bypass graft surgery within 30 days was also recorded. As described in the European guidelines, post-PCI myocardial infarction was defined as an association of suggestive symptoms or electrocardiographic changes with a significant elevation in troponin concentration [18] .
For long-term outcomes, data were collected annually by an experienced investigator who contacted all patients for a telephone interview. To complete the follow-up quality control, medical records from cardiologists and general practitioners were also collected and the data compared against the case report forms. The benefits of revascularization were evaluated at 20 months by comparing event-free survival rates among older patients according to the initial procedural outcome. Events were then defined as death, myocardial infarction and a need for revascularization (PCI or coronary artery bypass graft surgery). Patients who underwent a successful second CTO-PCI attempt within 3 months after failure of the first procedure were followed up from the date of the second PCI. Planned second attempts on the same lesion within 3 months were not recorded as events in the failure group.
The study protocol was approved by our institutional review board and all patients provided informed consent.
Statistical analysis
All continuous variables are described as mean and standard deviation (SD) or median and interquartile range (IQR). Categorical variables are presented as proportions. In bivariate analysis, qualitative variables were compared using the chi-square test (or the Fisher's exact test when necessary). Mean values of quantitative variables were compared using Student's t test. The Shapiro-Wilks and the Levene's tests, respectively, were used to test the normality of the variables' distributions and the homogeneity of variances. A non-parametric Mann-Whitney test was performed when basic assumptions of the Student's t test were not satisfied.
The association between patient baseline characteristics and the risk of a post-PCI event was assessed by multivariable logistic analysis. The model was built by applying a forward procedure. Included variables were selected based on the scientific literature. Continuous variables fulfilled log-linearity.
The cumulative survival of patients according to procedural outcome (success or failure) was determined by the Kaplan-Meier method and compared using the log-rank test. The relations between the patient baseline characteristics, procedural outcome and major adverse cardiac events (MACE; defined as acute coronary syndromes, cardiogenic shock, new percutaneous coronary revascularization or death) at 20 months were assessed using Cox proportional hazards regression analysis. The multivariable model was built by applying a forward procedure. Variables were included in the model if their P-value was <0.20 in the bivariate analysis or if they were clinically pertinent. All included variables met the hypothesis of risk proportionality. Continuous variables also fulfilled log-linearity. The final model was checked using the Cox-Snell residual test.
All statistical analyses were performed using STATA v11.2 (STATA Corporation, College Station, Texas). For all tests, a P-value of <0.05 was considered significant.
Results
Baseline characteristics
A total of 374 CTO-PCIs were performed in 356 patients. Ninety-three (26.1%) of the patients were ≥75 years old (median age: 80 years, IQR: 78-83). Medical history and prevalence of cardiovascular risk factors were broadly similar in the two age groups, but older patients appeared to be at higher risk of postoperative complications (Table 1) . Indeed, they tended to be referred more frequently for acute coronary syndromes (ACS) related to other lesions (40.9% vs. 30.4%; P = 0.07), and they had higher rates of chronic renal disease (P < 0.001) and symptoms of congestive heart failure on admission (P = 0.014). Angiographic findings revealed more complex and more extensive CAD in older patients: 55 (59%) had a CTO involving the left anterior descending artery and 78 (84%) had multivessel disease.
Procedural characteristics
Procedural characteristics were analysed by lesion for each CTO-PCI attempt. The rate of arterial access was similar in the two groups; 52.1% vs. 52.5% for radial access (P = 0.95), 29.2% vs. 32.7% for femoral access (P = 0.51), and 18.7% vs. 14.8% for both (P = 0.38), in younger and older patients, respectively. However, procedural techniques tended to differ between groups: retrograde wire crossing techniques were used less often with older patients (10.9% vs. 29.4%; P < 0.001) but complex atherectomy procedures were more frequent (16.8% vs. 2.8%; P < 0.001).
Overall success rates were 78.2% (n = 226) in younger patients and 74.3% (n = 75) in older patients (P = 0.42). In cases of procedural success, 98.7% of patients had stent implantations. Drug-eluting stents were used in 96.0% of younger patients and in 88.0% of older patients (P = 0.011). The mean fluoroscopy time (56 ± 33 min in younger patients vs. 52 ± 21 min in older patients; P = 0.55) and the procedural time (107 ± 52 min in patients under 75 years vs. 97 ± 32 min in older patients; P = 0.478) were similar in both groups but the volume of contrast agent used was higher in younger patients (281 ± 114 mL vs. 235 ± 84 mL; P = 0.003).
Outcomes at 30 days
The 30-day outcome data are presented in Table 2 . Rates of MACCE were significantly higher in older patients (5.4% vs. 0.4%; P = 0.005). One death was recorded in both groups for patients admitted with ACS involving a vessel other than the CTO vessel. Furthermore, among the older group, one patient, referred for severe congestive heart failure, died during hospitalization. Among patients ≥75 years, other post-procedural complications were post-PCI myocardial infarctions (three patients) and minor complications such as haemorrhage or transitional acute renal failure. Two patients ≥75 years underwent coronary artery bypass surgery within 30 days after the PCI attempt, but both cases involved elective surgery after PCI failure.
After adjustment for patient baseline characteristics (age, sex, history of chronic kidney disease, ACS at admission and multivessel CAD), the strongest predictors of post-PCI events (composite of MACCE, haemorrhage or acute renal failure) were age (OR: 1.1, 95% CI: 1.05-1.18) and sex (OR: 3.98, 95% CI: 1.44-10.93).
The median length of stay was 5 days (3-7) for patients ≥75 years and 4 days (3-5) for patients <75 years (P = 0.01).
Long-term follow-up
The long-term outcomes of CTO revascularization were assessed by analysing MACE-free survival according to CTO-PCI outcome. Analyses were conducted in patients ≥75 years, in whom the 20-month follow-up was 98% complete. During the first 3 months following CTO-PCI, two patients from the failure group underwent a second attempt at PCI, which was planned for the same target CTO. For both, recanalization could not be achieved and the second attempt of CTO-PCI was not recorded as an event.
As shown in Table 3 , baseline demographics and angiographic characteristics were broadly similar between patients who had a successful CTO recanalization and patients whose recanalization was unsuccessful, with the exception of age, hypercholesterolaemia, number of diseased vessels, history of PCI and rate of patients with CTO localized in the circumflex coronary artery.
After the 20-month follow-up, there was numerically lower but non-statistically significant difference in mortality rates between patients in the successful group and patients in the failure group (21.1% vs. 9.1%; P = 0.34). In contrast, rates of unstable angina (1.4% vs. 4.5% in success and failure groups, respectively), myocardial infarction (2.8% vs. 18.2%, respectively) and cardiogenic shock (2.8% vs. 4.5%, respectively) tended to be higher in the failure group (Table 4) . Similarly, despite optimal medical therapy, symptoms such as angina CCS ≥2 remained more frequent among the failure group (31.8% vs. 5.6%; P = 0.003), and five (22.7%) patients in this group required another PCI. Among patients who had successful recanalization, three (4.2%) cases of restenosis were recorded, and two (2.8%) patients required a new PCI during follow-up (Table 4) .
MACE-free survival was improved when patients had undergone a successful CTO revascularization (Fig. 1 ). After adjustment for age, sex, hypercholesterolaemia, diabetes, myocardial infarction, peripheral artery disease, PCI, CTO localization, ACS on admission and three-vessel disease, the determinants of MACE at 20 months were age (HR: 1.12, 95% CI: 1.03-1.23), history of myocardial infarction (HR: 2.77, 95% CI: 1.22-6.25) and successful CTO recanalization (HR: 0.43, 95% CI: 0.19-0.96; P = 0.039).
Discussion
Elderly CTO patients present a challenge for interventional cardiologists performing PCI. Indeed, previous studies have reported that age and CTO are both associated with higher rates of post-procedure complications and lower rates of procedural success. Nevertheless, recent studies have highlighted that older patients could benefit the most from revascularization [4] and CTO-PCI studies have reported an improvement in successful procedural recanalization [19] .
In accordance with these reports, our study shows that the success rate of CTO-PCI has improved and can now reach 75% in elderly patients. Moreover, to the best of our knowledge, this is one of the largest studies to demonstrate an improvement in the event-free survival following successful CTO-PCI in unselected patients aged ≥75 years. Values are number (%) or median (interquartile range). PCI: percutaneous coronary intervention; CABG: coronary artery bypass graft; MACCE: major adverse cardiac and cerebrovascular events. a Hospital death, stroke or myocardial infarction.
Figure 1.
Twenty-month outcomes for patients ≥75 years. MACE was the composite of acute coronary syndrome, cardiogenic shock, new percutaneous coronary revascularization or death. CTO: chronic total occlusion; HR: hazard ratio; MACE: major adverse cardiac events; PCI: percutaneous coronary intervention.
Post-procedural outcomes
As previously reported, the elderly patients in our study were more likely to have calcified multivessel CAD, which is usually associated with lower rates of procedural success [20] [21] [22] . Nowadays, CTO recanalization can be achieved in expert hands with a success rate similar to that seen in younger patients. The procedural techniques used had to be adapted for older patients. For example, they more often required complex atherectomy procedures using a Rotablator because of an increased prevalence of calcified lesions. Retrograde approaches were also used less frequently in older patients, probably because they frequently had multivessel CAD restricting the collateral crossing and the strategies of PCI. With regard to the safety of CTO-PCI, we found that post-PCI complications were more frequent in the older group. However, older patients referred for PCI were also at higher risk of complications than younger patients: they had more extended CAD and they had a higher risk profile, including severe comorbidities, thus making coronary artery bypass graft surgery unreasonable. Regarding minor postoperative complications, we expect that appropriated periprocedural management could reduce haemorrhages or contrast-induced nephropathies. In that way, we took preference to radial approach to avoid bleeding and we systematically achieved renal protection by saline perfusion infusion before CTO-PCI.
Benefits of recanalization
In accordance with previous studies, we demonstrate that symptoms were better relieved and that event-free survival was improved in patients who had successful CTO-PCI [11] . Furthermore, our research highlights that patients ≥75 years also benefit from CTO-PCI recanalization. Although the improved event-free survival was mainly due to a reduced need for further revascularization (coronary artery bypass graft surgery or PCI), we still demonstrated a reduction in the rate of complications, such as ACS or cardiogenic shock, when CTO-PCI was successfully achieved. However, in contrast to published findings in the general population [12, 23] , survival was not significantly associated with successful CTO recanalization in our study. Similar results have emerged recently from the only other study of CTO-PCI in elderly patients [24] . The lack of such studies can probably be explained by the difficulty in evaluating specific mortality rates in the elderly. In any case, the observed 81.5% decrease in ACS rate and 37.8% decrease in the frequency of cardiogenic shock among patients who underwent successful CTO-PCI support the hypothesis that CTO recanalization improves survival [25] .
To complete the assessment of CTO-PCI in elderly patients, we propose that future studies should consider patient quality of life and analyse cost-effectiveness. These probably present the most challenging issues as far as older patients are concerned.
Limitations
The major limitation of this study relates to the recruitment of the population: our study is a single-centre analysis of patients referred for CAD invasive management in a tertiary care centre. Consequently, our findings are restricted to patients selected to undergo PCI and to the procedural outcomes for CTO-PCI trained operators. Another major limitation concerns the lack of power in our analysis: despite being a high-volume centre, our cohort of patients ≥75 years was relatively small. Moreover, we included patients referred for both stable and unstable CAD. The small sample size probably led to a lack of power in the survival analysis and in-hospital mortality was probably increased due to the inclusion of patients admitted for ACS. However, our study is probably closer to reallife practice than a controlled series or previous reports because we have examined older CTO patients that are frequently affected by severe comorbidities such as diabetes, previous myocardial infarction or chronic kidney disease [24] . Similarly, the length of follow-up was voluntarily reduced to 20 months to better accommodate the question of elderly patients. Analysing midterm complications is also more appropriate when considering patients ≥75 years. The final limitation of our registry was the absence of accurate angiographic descriptions of the CAD complexity, which made inter-group comparisons of CAD difficult. However, the SYNTAX score, which is the most commonly used classification, was not appropriate here because most of our patients did not have left-main or threevessel CAD. Moreover it seems to be of limited use in the field of CTO. 
Conclusions
Our study has demonstrated the feasibility of CTO-PCI in patients ≥75 years, despite a slight increase in the rate of postoperative complications. We have shown that successful CTO-PCI recanalization is associated with improved 20-month event-free survival. These results suggest that CTO-PCI could be an interesting alternative strategy to treat selected elderly patients who require myocardial revascularization.
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